Mycobacterium heckeshornense lumbar spondylodiskitis in a patient with rheumatoid arthritis receiving etanercept treatment

Journal of Rheumatology

Volumn 36, Issue 9, 2009, Pages 2130-2131

  Elyousfi, Abdulhamid A ^a   Leiter, Jeff R S ^a,b   Goytan, Micheal J ^a   Robinson, David B ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Pan Am Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CORTICOSTEROID; ETANERCEPT; MOXIFLOXACIN; RIFAMPICIN;

ABSCESS; ADULT; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; KNEE ARTHROPLASTY; LETTER; LUMBAR VERTEBRA; MALE; MYCOBACTERIUM HECKESHORNENSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAVERTEBRAL ABSCESS; PRIORITY JOURNAL; PROPIONIBACTERIUM; RHEUMATOID ARTHRITIS; SPINE FUSION; SPONDYLITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISCITIS; HUMANS; IMMUNOGLOBULIN G; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYCOBACTERIUM; OPPORTUNISTIC INFECTIONS; RECEPTORS, TUMOR NECROSIS FACTOR; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349254781     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090056     Document Type: Letter

References (7)

1. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999;130:478-486
2. Gomez-Reino JJ, Carmona L, Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007;57:756-761 (Pubitemid 46932080)
3. Maimon N, Brunton J, Chan AK, Marras TK. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax 2007;62:739-740 (Pubitemid 47235021)
4. Roth A, Reischl U, Schonfeld N, et al. Mycobacterium heckeshornense sp. nov., a new pathogenic slowly growing Mycobacterium sp. causing cavitary lung disease in an immunocompetent patient. J Clin Microbiol 2000;38:4102-4107 (Pubitemid 32233211)
5. Godreuil S, Marchandin H, Terru D, et al. Mycobacterium heckeshornense tenosynovitis. Scand J Infect Dis 2006;38:1098-1101
6. Jaureguy F, Ioos V, Marzouk P, et al. Mycobacterium heckeshornense: an emerging pathogen responsible for a recurrent lung infection. J Infect 2007;54:e33-5. (Pubitemid 44939361)
7. van Hest R, van der Zanden A, Boeree M, et al. Mycobacterium heckeshornense infection in an immunocompetent patient and identification by 16S rRNA sequence analysis of culture material and a histopathology tissue specimen. J Clin Microbiol 2004;42:4386-4389 (Pubitemid 39296184)